Hormonal modulation of endothelial NO production.

PubWeight™: 1.26‹?› | Rank: Top 10%

🔗 View Article (PMC 2865573)

Published in Pflugers Arch on March 07, 2010

Authors

Sue P Duckles1, Virginia M Miller

Author Affiliations

1: Pharmacology, University of California, Irvine, School of Medicine, Irvine, CA 92697-4625, USA. spduckle@uci.edu

Articles citing this

Peroxynitrite decomposition with FeTMPyP improves plasma-induced vascular dysfunction and infarction during mild but not severe hyperglycemic stroke. J Cereb Blood Flow Metab (2012) 0.98

Potential role of intermedin/adrenomedullin 2 in early embryonic development in rats. Regul Pept (2011) 0.91

How mental stress affects endothelial function. Pflugers Arch (2011) 0.90

Should there be sex-specific criteria for the diagnosis and treatment of heart failure? J Cardiovasc Transl Res (2013) 0.87

Strategies and methods to study sex differences in cardiovascular structure and function: a guide for basic scientists. Biol Sex Differ (2011) 0.84

Sex, hormones and neuroeffector mechanisms. Acta Physiol (Oxf) (2010) 0.83

Prolactin protects retinal pigment epithelium by inhibiting sirtuin 2-dependent cell death. EBioMedicine (2016) 0.83

Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause. Biol Sex Differ (2013) 0.83

Constrictor prostanoids and uridine adenosine tetraphosphate: vascular mediators and therapeutic targets in hypertension and diabetes. Br J Pharmacol (2015) 0.82

Mechanisms of cerebrovascular protection: oestrogen, inflammation and mitochondria. Acta Physiol (Oxf) (2010) 0.82

Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease. Womens Health (Lond Engl) (2015) 0.82

Female resistance to pneumonia identifies lung macrophage nitric oxide synthase-3 as a therapeutic target. Elife (2014) 0.82

Stress-related programming of autonomic imbalance: role in allergy and asthma. Chem Immunol Allergy (2012) 0.81

The prolactin family hormones regulate vascular tone through NO and prostacyclin production in isolated rat aortic rings. Acta Pharmacol Sin (2015) 0.81

Assessment of endothelial dysfunction in childhood obesity and clinical use. Oxid Med Cell Longev (2013) 0.81

Local versus systemic influences on uterine vascular reactivity during pregnancy in the single-horn gravid rat. Reprod Sci (2011) 0.80

Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets. Physiol Rep (2014) 0.79

Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function. Am J Physiol Lung Cell Mol Physiol (2015) 0.79

Genotype-related effect of crowding stress on blood pressure and vascular function in young female rats. Biomed Res Int (2014) 0.78

Implications for reproductive medicine: Sex differences in cardiovascular disease. Sex Reprod Menopause (2011) 0.78

Association of endothelial nitric oxide synthase gene polymorphisms with endometrial carcinoma: a preliminary study. J Turk Ger Gynecol Assoc (2011) 0.78

Therapeutic Efficacy of an ω-3-Fatty Acid-Containing 17-β Estradiol Nano-Delivery System against Experimental Atherosclerosis. PLoS One (2016) 0.77

Congress on women's health Trudy Bush lecture 2014: new insights into sex Hormones and Cardiovascular disease. J Womens Health (Larchmt) (2014) 0.77

Dynamics of enhanced mitochondrial respiration in female compared with male rat cerebral arteries. Am J Physiol Heart Circ Physiol (2015) 0.77

Progesterone supplementation attenuates hypertension and the autoantibody to the angiotensin II type I receptor in response to elevated interleukin-6 during pregnancy. Am J Obstet Gynecol (2014) 0.77

R- and S-equol have equivalent cytoprotective effects in Friedreich's ataxia. BMC Pharmacol Toxicol (2012) 0.76

Association of insulin resistance with overactive bladder in female patients. Int Neurourol J (2012) 0.76

Risk factors for cardiovascular disease in women with diabetes. Gend Med (2010) 0.76

Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia. Curr Hypertens Rep (2017) 0.75

Age and gender differences in the influences of eNOS T-786C polymorphism on arteriosclerotic parameters in general population in Japan. Environ Health Prev Med (2016) 0.75

Increased bladder wall thickness in diabetic and nondiabetic women with overactive bladder. Int Neurourol J (2013) 0.75

Correlation between polymorphism of endothelial nitric oxide synthase and avascular necrosis of femoral head. Int J Clin Exp Med (2015) 0.75

Low-dose testosterone alleviates vascular damage caused by castration in male rats in puberty via modulation of the PI3K/AKT signaling pathway. Mol Med Rep (2016) 0.75

Sex hormone therapy and progression of cardiovascular disease in menopausal women. Clin Sci (Lond) (2016) 0.75

A relative L-arginine deficiency contributes to endothelial dysfunction across the stages of the menopausal transition. Physiol Rep (2017) 0.75

Endothelial Dysfunction Markers in Low Cardiovascular Risk Individuals: Comparison of Males and Females. J Med Biochem (2017) 0.75

Articles cited by this

(truncated to the top 100)

Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol (2004) 5.34

Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells. Proc Natl Acad Sci U S A (1990) 4.49

Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J Clin Invest (2000) 3.79

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation (1987) 3.49

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest (1994) 3.49

Cardiovascular actions of insulin. Endocr Rev (2007) 3.48

Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest (1999) 3.18

Androgens and cardiovascular disease. Endocr Rev (2003) 2.71

Vascular actions of estrogens: functional implications. Pharmacol Rev (2008) 2.52

Nitric oxide and pregnancy. Am J Physiol (1997) 2.38

Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat. Biochem Biophys Res Commun (1990) 2.31

Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo : a specific vascular action of insulin. Circulation (2000) 2.18

Sex difference in resting pituitary-adrenal function in the rat. Am J Physiol (1963) 2.17

Endogenous estrogens influence endothelial function in young men. Circ Res (2003) 1.98

Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem (2004) 1.96

Noncontraceptive estrogen use and cardiovascular disease. Epidemiol Rev (1985) 1.95

Plasma membrane estrogen receptors. Trends Endocrinol Metab (2009) 1.85

Prolactin: the new biology of an old hormone. Annu Rev Physiol (2002) 1.82

Modulation of antioxidant enzyme expression and function by estrogen. Circ Res (2003) 1.79

Rapid nongenomic actions of thyroid hormone. Proc Natl Acad Sci U S A (2006) 1.79

Effect of 17 beta-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther (1988) 1.57

Certain progestins prevent the enhancing effect of 17beta-estradiol on NO-mediated inhibition of platelet aggregation by endothelial cells. Arterioscler Thromb Vasc Biol (2008) 1.57

Insulin at physiological concentrations selectively activates insulin but not insulin-like growth factor I (IGF-I) or insulin/IGF-I hybrid receptors in endothelial cells. Endocrinology (2005) 1.55

Chronic treatment with progesterone but not medroxyprogesterone acetate restores the endothelial control of vascular tone in the mesenteric artery of ovariectomized rats. Menopause (2004) 1.50

Minireview: estrogen receptor-mediated rapid signaling. Endocrinology (2006) 1.49

Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol (2005) 1.47

Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. J Clin Invest (1993) 1.45

Endothelium-dependent relaxation in aorta of BB rat. Diabetes (1987) 1.44

Testosterone relaxes coronary arteries by opening the large-conductance, calcium-activated potassium channel. Am J Physiol Heart Circ Physiol (2001) 1.42

Estrogen reduces myogenic tone through a nitric oxide-dependent mechanism in rat cerebral arteries. Am J Physiol (1998) 1.41

Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res (2003) 1.32

Impaired acetylcholine-induced release of nitric oxide in the aorta of male aromatase-knockout mice: regulation of nitric oxide production by endogenous sex hormones in males. Circ Res (2003) 1.28

Glucocorticoids and vascular reactivity. Curr Vasc Pharmacol (2004) 1.26

Cushing, cortisol, and cardiovascular disease. Hypertension (2000) 1.21

Estrogen and progesterone receptors: from molecular structures to clinical targets. Cell Mol Life Sci (2009) 1.16

Sex steroids and endothelial function: translating basic science to clinical practice. Trends Pharmacol Sci (2007) 1.15

Long-term estrogen therapy improves vascular function in male to female transsexuals. J Am Coll Cardiol (1997) 1.15

Glucocorticoid response elements and 11 beta-hydroxysteroid dehydrogenases in the regulation of endothelial nitric oxide synthase expression. Cardiovasc Res (2008) 1.15

Psychosocial factors, sex differences, and atherosclerosis: lessons from animal models. Psychosom Med (1997) 1.13

Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. Circulation (1998) 1.13

Cardiovascular risk and subclinical hypothyroidism: focus on lipids and new emerging risk factors. What is the evidence? Thyroid (2007) 1.11

Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke (1999) 1.11

Estrogen increases endothelial nitric oxide synthase via estrogen receptors in rat cerebral blood vessels: effect preserved after concurrent treatment with medroxyprogesterone acetate or progesterone. Stroke (2002) 1.11

Vascular endothelial estrogen receptor alpha is modulated by estrogen status and related to endothelial function and endothelial nitric oxide synthase in healthy women. J Clin Endocrinol Metab (2009) 1.07

Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol (1991) 1.07

Insulin signalling: metabolic pathways and mechanisms for specificity. Cell Signal (1999) 1.07

Benefits and risks of menopausal estrogen and/or progestin hormone use. Prev Med (1988) 1.06

Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets. Am J Physiol (1994) 1.02

Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation (1997) 1.02

Effect of increasing age on the endothelium-mediated relaxation of rat blood vessels in vitro. J Pharmacol Exp Ther (1987) 1.01

Insulin enhances the expression of the endothelial nitric oxide synthase in native endothelial cells: a dual role for Akt and AP-1. Nitric Oxide (2003) 1.00

Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study. J Clin Invest (1996) 1.00

Endothelial dysfunction in a man with disruptive mutation in oestrogen-receptor gene. Lancet (1997) 1.00

Vascular nitric oxide and superoxide anion contribute to sex-specific programmed cardiovascular physiology in mice. Am J Physiol Regul Integr Comp Physiol (2009) 0.99

Glucocorticoid receptor dynamics and gene regulation. Stress (2009) 0.99

Vascular cell signaling by membrane estrogen receptors. Steroids (2005) 0.99

Dehydroepiandrosterone modulates endothelial nitric oxide synthesis via direct genomic and nongenomic mechanisms. Endocrinology (2003) 0.97

Differential signal transduction of progesterone and medroxyprogesterone acetate in human endothelial cells. Endocrinology (2004) 0.96

The vascular endothelium in hypertension. Handb Exp Pharmacol (2006) 0.95

Selected contribution: cerebrovascular nos and cyclooxygenase are unaffected by estrogen in mice lacking estrogen receptor-alpha. J Appl Physiol (1985) (2001) 0.95

Effect of medroxyprogesterone acetate on endothelium-dependent vasodilation in postmenopausal women receiving estrogen. Circulation (2001) 0.95

Medroxyprogesterone attenuates estrogen-mediated inhibition of neointima formation after balloon injury of the rat carotid artery. Circulation (1996) 0.94

17 Beta-estradiol increases endothelial nitric oxide synthase mRNA copy number in cerebral blood vessels: quantification by real-time polymerase chain reaction. Eur J Pharmacol (2003) 0.94

Clinical review 110: Cardiovascular actions of estrogens in men. J Clin Endocrinol Metab (1999) 0.93

Androgenic/estrogenic balance in the male rat cerebral circulation: metabolic enzymes and sex steroid receptors. J Cereb Blood Flow Metab (2007) 0.93

Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport. J Biol Chem (1996) 0.92

Prolactin induces regional vasoconstriction through the beta2-adrenergic and nitric oxide mechanisms. Endocrinology (2007) 0.92

Plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension (1995) 0.92

Vascular reactivity is impaired in genetic females taking high-dose androgens. J Am Coll Cardiol (1998) 0.91

16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology (2004) 0.90

The nitric oxide system in glucocorticoid-induced hypertension. J Hypertens (2002) 0.89

Acute effects of growth hormone on vascular function in human subjects. J Clin Endocrinol Metab (2003) 0.89

Growth hormone induces eNOS expression and nitric oxide release in a cultured human endothelial cell line. FEBS Lett (2003) 0.88

Heart failure and its treatment in women. Role of hypertension, diabetes, and estrogen. Herz (2005) 0.87

Dual effects of insulin-like growth factor-I on the constitutive and inducible nitric oxide (NO) synthase-dependent formation of NO in vascular cells. J Endocrinol Invest (1999) 0.87

Differential effects of chronic treatment with estrogen receptor ligands on regulation of nitric oxide synthase in porcine aortic endothelial cells. J Cardiovasc Pharmacol (2006) 0.86

Endothelium-dependent responses in coronary arteries are changed with puberty in male pigs. Am J Physiol Heart Circ Physiol (2003) 0.86

17beta-estradiol inhibits cyclic strain-induced endothelin-1 gene expression within vascular endothelial cells. Am J Physiol Heart Circ Physiol (2004) 0.85

Effects of nonsteroidal phospholipase inhibitors and glucocorticoids on endothelium-dependent relaxations of rabbit aorta induced by different agents. J Cardiovasc Pharmacol (1987) 0.85

Differential regulation of 11 beta-hydroxysteroid dehydrogenase type 1 and 2 by nitric oxide in cultured human placental trophoblast and chorionic cell preparation. Endocrinology (1997) 0.85

GH and IGF-I regulate the expression of endothelial nitric oxide synthase (eNOS) in cardiovascular tissues of hypophysectomized female rats. Eur J Endocrinol (2002) 0.85

Effects of progesterone and estrogen on endothelial dysfunction in porcine coronary arteries. J Surg Res (2005) 0.85

Abnormal vascular reactivity in growth hormone deficiency. Circulation (2001) 0.84

Interference of progestins with endothelial actions of estrogens: a matter of glucocorticoid action or deprivation? Arterioscler Thromb Vasc Biol (2009) 0.83

Treating hypothyroidism improves endothelial function. Metabolism (2004) 0.83

Short-term administration of growth hormone (GH) lowers blood pressure by activating eNOS/nitric oxide (NO)-pathway in male hypophysectomized (Hx) rats. BMC Physiol (2005) 0.83

Hormonal regulation of normal vascular tone in males. Circ Res (2003) 0.82

Progesterone-modulation of estrogen action: rapid down regulation of nuclear acceptor sites for the estrogen receptor. Adv Exp Med Biol (1987) 0.81

Membrane-bound progesterone receptor expression in human aortic endothelial cells. J Histochem Cytochem (2003) 0.81

Mental stress induces sustained elevation of blood pressure and lipid peroxidation in postmenopausal women. Life Sci (2007) 0.80

Growth hormone exerts acute vascular effects independent of systemic or muscle insulin-like growth factor I. J Clin Endocrinol Metab (2008) 0.80

Progestins overcome inhibition of platelet aggregation by endothelial cells by down-regulating endothelial NO synthase via glucocorticoid receptors. FASEB J (2006) 0.80

Effect of nitric oxide on prolactin secretion and hypothalamic biogenic amine contents. Life Sci (2004) 0.80

Relation of depression to coronary endothelial function. Am J Cardiol (2007) 0.79

Cross-talk between rapid and long term effects of progesterone on vascular tissue. J Steroid Biochem Mol Biol (2009) 0.78

Depression and cardiovascular disease: role of nitric oxide. Cardiovasc Hematol Agents Med Chem (2008) 0.78

Chronic inhibition of nitric oxide synthase augments the ACTH response to exercise. Am J Physiol Regul Integr Comp Physiol (2009) 0.78

Dual immunosuppression enhances vasomotor injury: interactive effect between endothelin-1 and nitric oxide bioavailability. J Thorac Cardiovasc Surg (2008) 0.77

Estrogen modulates the action of nitric oxide in the medial preoptic area on luteinizing hormone and prolactin secretion. Life Sci (2004) 0.77

Hypothyroidism is associated with signs of endothelial dysfunction despite 1-year replacement therapy with levothyroxine. Clin Endocrinol (Oxf) (2008) 0.76

Articles by these authors

Arterial imaging outcomes and cardiovascular risk factors in recently menopausal women: a randomized trial. Ann Intern Med (2014) 2.48

Advancing the study of stroke in women: summary and recommendations for future research from an NINDS-Sponsored Multidisciplinary Working Group. Stroke (2006) 2.17

Premature menopause or early menopause and risk of ischemic stroke. Menopause (2012) 1.84

Considerations of sex and gender differences in preclinical and clinical trials. Handb Exp Pharmacol (2012) 1.77

Women, hormones, and clinical trials: a beginning, not an end. J Appl Physiol (1985) (2005) 1.60

Methodology for isolation, identification and characterization of microvesicles in peripheral blood. J Immunol Methods (2011) 1.58

Effects of estrogen with micronized progesterone on cortical and trabecular bone mass and microstructure in recently postmenopausal women. J Clin Endocrinol Metab (2013) 1.51

Characterization of blood borne microparticles as markers of premature coronary calcification in newly menopausal women. Am J Physiol Heart Circ Physiol (2008) 1.44

Cell biology of pathologic renal calcification: contribution of crystal transcytosis, cell-mediated calcification, and nanoparticles. J Investig Med (2006) 1.29

Postmenopausal hormone therapy: new questions and the case for new clinical trials. Menopause (2006) 1.18

In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. J Appl Physiol (1985) (2006) 1.13

Maternal recall of hypertensive disorders in pregnancy: a systematic review. J Womens Health (Larchmt) (2012) 1.11

Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk. J Cardiovasc Transl Res (2011) 1.11

In pursuit of scientific excellence: sex matters. Am J Physiol Cell Physiol (2012) 1.08

Human-derived nanoparticles and vascular response to injury in rabbit carotid arteries: proof of principle. Int J Nanomedicine (2008) 1.08

Sex differences and sex steroids in lung health and disease. Endocr Rev (2012) 1.07

Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes. Am J Med (2011) 1.02

Proteomic evaluation of biological nanoparticles isolated from human kidney stones and calcified arteries. Acta Biomater (2010) 1.02

Search for microbial signatures within human and microbial calcifications using soft x-ray spectromicroscopy. J Investig Med (2006) 1.01

Sex/gender medicine. The biological basis for personalized care in cardiovascular medicine. Circ J (2009) 1.01

Thrombogenic microvesicles and white matter hyperintensities in postmenopausal women. Neurology (2013) 1.01

Intimal estrogen receptor (ER)beta, but not ERalpha expression, is correlated with coronary calcification and atherosclerosis in pre- and postmenopausal women. J Clin Endocrinol Metab (2006) 1.00

Correlating androgen and estrogen steroid receptor expression with coronary calcification and atherosclerosis in men without known coronary artery disease. J Clin Endocrinol Metab (2004) 0.99

In pursuit of scientific excellence: sex matters. Am J Physiol Heart Circ Physiol (2012) 0.98

Differential effects of 17beta-estradiol, conjugated equine estrogen, and raloxifene on mRNA expression, aggregation, and secretion in platelets. Am J Physiol Heart Circ Physiol (2005) 0.95

Systemic injection of planktonic forms of mammalian-derived nanoparticles alters arterial response to injury in rabbits. Am J Physiol Heart Circ Physiol (2009) 0.94

Loss of estrogen receptor beta decreases mitochondrial energetic potential and increases thrombogenicity of platelets in aged female mice. Age (Dordr) (2009) 0.93

Acrocyanosis: the Flying Dutchman. Vasc Med (2011) 0.93

Sex-specific changes in platelet aggregation and secretion with sexual maturity in pigs. J Appl Physiol (1985) (2004) 0.91

Characterization of biofilm formed by human-derived nanoparticles. Nanomedicine (Lond) (2009) 0.90

Key role of alkaline phosphatase in the development of human-derived nanoparticles in vitro. Acta Biomater (2010) 0.90

Rationale and design of the Kronos Early Estrogen Prevention Study (KEEPS) and the KEEPS Cognitive and Affective sub study (KEEPS Cog). Brain Res (2013) 0.89

Pilot study of sex differences in chemokine/cytokine markers of atherosclerosis in humans. Gend Med (2008) 0.89

Fellatio-associated petechiae of the palate: report of purpuric palatal lesions developing after oral sex. Dermatol Online J (2013) 0.89

Ovariectomy upregulates expression of estrogen receptors, NOS, and HSPs in porcine platelets. Am J Physiol Heart Circ Physiol (2002) 0.88

Should there be sex-specific criteria for the diagnosis and treatment of heart failure? J Cardiovasc Transl Res (2013) 0.87

Platelet characteristics change with aging: role of estrogen receptor beta. J Gerontol A Biol Sci Med Sci (2005) 0.87

Go Red for Women cardiovascular health-screening evaluation: the dichotomy between awareness and perception of cardiovascular risk in the community. J Womens Health (Larchmt) (2013) 0.87

Endothelium-dependent responses in coronary arteries are changed with puberty in male pigs. Am J Physiol Heart Circ Physiol (2003) 0.86

Hypertension in pregnancy is a risk factor for peripheral arterial disease decades after pregnancy. Atherosclerosis (2013) 0.86

Human platelets contain estrogen receptor alpha, caveolin-1 and estrogen receptor associated proteins. Platelets (2003) 0.86

Differential effects of chronic treatment with estrogen receptor ligands on regulation of nitric oxide synthase in porcine aortic endothelial cells. J Cardiovasc Pharmacol (2006) 0.86

Microvesicles at the crossroads between infection and cardiovascular diseases. J Cardiovasc Pharmacol (2012) 0.86

Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS). Fertil Steril (2013) 0.83

Differential effects of 17beta-estradiol and raloxifene on VSMC phenotype and expression of osteoblast-associated proteins. Am J Physiol Endocrinol Metab (2005) 0.83

Human leukocyte antigen class II immune response genes, female gender, and cigarette smoking as risk and modulating factors in abdominal aortic aneurysms. J Vasc Surg (2002) 0.82

Aggregation and microparticle production through toll-like receptor 4 activation in platelets from recently menopausal women. J Cardiovasc Pharmacol (2009) 0.81

In pursuit of scientific excellence: sex matters. Am J Physiol Regul Integr Comp Physiol (2012) 0.81

Leukocyte- and platelet-derived microvesicle interactions following in vitro and in vivo activation of toll-like receptor 4 by lipopolysaccharide. PLoS One (2011) 0.80

Estrogenic regulation of tissue factor and tissue factor pathway inhibitor in platelets. Am J Physiol Heart Circ Physiol (2005) 0.80

Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance. PLoS One (2013) 0.80

Platelet response as a sentinel marker of toll-like receptor 4 activation in mice. Thromb Res (2009) 0.80

In pursuit of scientific excellence: sex matters. Am J Physiol Endocrinol Metab (2012) 0.79

Estrogen metabolomics: a physiologist's perspective. Hypertension (2010) 0.79

The association of matrix Gla protein isomers with calcification in capsules surrounding silicone breast implants. Biomaterials (2011) 0.79

Ectopic fat and adipokines in metabolically benign overweight/obese women: the Kronos Early Estrogen Prevention Study. Obesity (Silver Spring) (2013) 0.79

Contribution of biologically derived nanoparticles to disease. Surgery (2009) 0.79

Effects of ovariectomy on aggregation, secretion, and metalloproteinases in porcine platelets. Am J Physiol Heart Circ Physiol (2003) 0.79

Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets. Physiol Rep (2014) 0.79

In pursuit of scientific excellence: sex matters. J Appl Physiol (1985) (2012) 0.78

Treatment with raloxifene and 17beta-estradiol differentially modulates nitric oxide and prostanoids in venous endothelium and platelets of ovariectomized pigs. J Cardiovasc Pharmacol (2006) 0.78

Effect of puberty on coronary arteries from female pigs. J Appl Physiol (1985) (2003) 0.78

Mechanisms of estrogenic vascular protection. Am J Physiol Heart Circ Physiol (2006) 0.77

Species characterization of plasma nitrite/nitrate (NOx) concentration. Comp Med (2003) 0.77

Effects of different hormone therapies on breast pain in recently postmenopausal women: findings from the Mayo Clinic KEEPS breast pain ancillary study. J Womens Health (Larchmt) (2014) 0.77

Effects of sex and gender on adaptations to space: reproductive health. J Womens Health (Larchmt) (2014) 0.77

Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review. Obstet Gynecol (2017) 0.76

In pursuit of scientific excellence: sex matters. Physiol Genomics (2012) 0.76

In pursuit of scientific excellence: sex matters. Am J Physiol Lung Cell Mol Physiol (2012) 0.76

Of mice, men, and hormones. Arterioscler Thromb Vasc Biol (2004) 0.76

Isolation, propagation, and analysis of biological nanoparticles. Methods Mol Biol (2011) 0.76

Mechanism of raloxifene-induced relaxation in femoral veins depends on ovarian hormonal status. J Cardiovasc Pharmacol (2002) 0.76

In pursuit of scientific excellence: sex matters. Adv Physiol Educ (2012) 0.76

Plasma levels of nitrite and nitrate in early and recent classes of fish. Comp Med (2008) 0.75

Influence of SULT1A1 genetic variation on age at menopause, estrogen levels, and response to hormone therapy in recently postmenopausal white women. Menopause (2016) 0.75

Longitudinal changes in menopausal symptoms comparing women randomized to low-dose oral conjugated estrogens or transdermal estradiol plus micronized progesterone versus placebo: the Kronos Early Estrogen Prevention Study. Menopause (2016) 0.75

Pulmonary arterial reactivity during induced infection of single lung allografts. Eur J Cardiothorac Surg (2007) 0.75

Sex-based physiology prior to political correctness. Am J Physiol Endocrinol Metab (2005) 0.75

Association of vasomotor symptoms and sleep apnea risk in midlife women. Menopause (2017) 0.75

Effects of oral versus transdermal menopausal hormone treatments on self-reported sleep domains and their association with vasomotor symptoms in recently menopausal women enrolled in the Kronos Early Estrogen Prevention Study (KEEPS). Menopause (2017) 0.75

Influence of preeclampsia and late-life hypertension on MRI measures of cortical atrophy. J Hypertens (2017) 0.75

Endothelial function in pigs transgenic for human complement regulating factor. Transplantation (2002) 0.75

In pursuit of scientific excellence: sex matters. Am J Physiol Gastrointest Liver Physiol (2012) 0.75

In pursuit of scientific excellence: sex matters. Am J Physiol Renal Physiol (2012) 0.75